Research ExplorerPublications[Treatment of paraphilia and sexually aggressive impulsive b...

[Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate]

Standard

[Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate]. / Briken, Peer; Berner, W; Noldus, J; Nika, E; Michl, U.

In: NERVENARZT, Vol. 71, No. 5, 5, 2000, p. 380-385.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Briken, P, Berner, W, Noldus, J, Nika, E & Michl, U 2000, '[Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate]', NERVENARZT, vol. 71, no. 5, 5, pp. 380-385. <http://www.ncbi.nlm.nih.gov/pubmed/10846713?dopt=Citation>

APA

Briken, P., Berner, W., Noldus, J., Nika, E., & Michl, U. (2000). [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate]. NERVENARZT, 71(5), 380-385. [5]. http://www.ncbi.nlm.nih.gov/pubmed/10846713?dopt=Citation

Vancouver

Briken P, Berner W, Noldus J, Nika E, Michl U. [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate]. NERVENARZT. 2000;71(5):380-385. 5.

Bibtex

@article{cd36bc0a2a0c44ab89d3adfc32a527db,
title = "[Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate]",
abstract = "Up to now there are no published results of therapy of paraphilia (Pedophilia, Sadism) and sexual aggressive impulsiveness with LHRH-(luteinizing hormone-releasing hormone) Agonists in the Germanspeaking countries. In this report we describe 11 patients which were treated with the LHRH-Agonist Leuprolide Acetate in a period of 12 months. The patients showed no tendency of sexual aggressive behaviour and reported an evident reduction of penile erection, ejaculation, masturbation, sexual deviant impulsiveness and fantasies. One patient died from suicide. In combination with other treatments LHRH-Agonists seem to be a very promising alternative to cyproterone acetate and its possible carcinogene effects.",
author = "Peer Briken and W Berner and J Noldus and E Nika and U Michl",
year = "2000",
language = "Deutsch",
volume = "71",
pages = "380--385",
journal = "NERVENARZT",
issn = "0028-2804",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate]

AU - Briken, Peer

AU - Berner, W

AU - Noldus, J

AU - Nika, E

AU - Michl, U

PY - 2000

Y1 - 2000

N2 - Up to now there are no published results of therapy of paraphilia (Pedophilia, Sadism) and sexual aggressive impulsiveness with LHRH-(luteinizing hormone-releasing hormone) Agonists in the Germanspeaking countries. In this report we describe 11 patients which were treated with the LHRH-Agonist Leuprolide Acetate in a period of 12 months. The patients showed no tendency of sexual aggressive behaviour and reported an evident reduction of penile erection, ejaculation, masturbation, sexual deviant impulsiveness and fantasies. One patient died from suicide. In combination with other treatments LHRH-Agonists seem to be a very promising alternative to cyproterone acetate and its possible carcinogene effects.

AB - Up to now there are no published results of therapy of paraphilia (Pedophilia, Sadism) and sexual aggressive impulsiveness with LHRH-(luteinizing hormone-releasing hormone) Agonists in the Germanspeaking countries. In this report we describe 11 patients which were treated with the LHRH-Agonist Leuprolide Acetate in a period of 12 months. The patients showed no tendency of sexual aggressive behaviour and reported an evident reduction of penile erection, ejaculation, masturbation, sexual deviant impulsiveness and fantasies. One patient died from suicide. In combination with other treatments LHRH-Agonists seem to be a very promising alternative to cyproterone acetate and its possible carcinogene effects.

M3 - SCORING: Zeitschriftenaufsatz

VL - 71

SP - 380

EP - 385

JO - NERVENARZT

JF - NERVENARZT

SN - 0028-2804

IS - 5

M1 - 5

ER -